
Rubrik Pharmaceuticals Private Limited
Founded in 2018 and headquartered in Delhi, India.
Founded in 2018 and headquartered in Delhi, India.
North West Delhi, Delhi, India
+91-XXXXXXXXXX
U51909DL2018PTC340182
340182
Private Limited Indian Non-Government Company
05 Oct 2018
02 Oct 2020
31 Mar 2020
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajbir Singh ![]() | Director | 05-Oct-2018 | Current |
Parmjit Kaur ![]() | Director | 05-Oct-2018 | Current |
Enhance accessibility to Rubrik Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Rubrik Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rubrik Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rubrik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rubrik Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rubrik Pharmaceuticals Private Limited last Annual general meeting of members was held on 02 Oct 2020 as per latest MCA records.
Rubrik Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi.
Rajbir Singh was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 6 years 8 months .
Parmjit Kaur was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 6 years 8 months .
Rubrik Pharmaceuticals Private Limited was registered on 05 Oct 2018 with Roc Delhi & aged 6 years 8 months as per MCA records.
Rubrik Pharmaceuticals Private Limited was incorporated on 05 Oct 2018.
The authorized share capital of Rubrik Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Rubrik Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rubrik Pharmaceuticals Private Limited is D 3/67 First Floor Sector 16, Rohini, New Delhi North West, India, 110089.
The corporate identification number (CIN) of Rubrik Pharmaceuticals Private Limited is U51909DL2018PTC340182 and the company number is 340182 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Rubrik Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.
Search company & director profiles for free and gain access to critical business data.